# Senate Advances Bill to Reduce US Pharmaceutical Dependence on China
Bipartisan US senators unveiled legislation on Wednesday aimed at curbing American reliance on China in the pharmaceutical and biotechnology industries. The bill seeks to increase scrutiny of Chinese investment in these sectors as part of Washington's broader strategic competition with Beijing.
The legislation represents an expansion of US concerns about supply chain vulnerability beyond semiconductors and artificial intelligence into the healthcare sector. By targeting Chinese pharmaceutical and biotechnology investments, lawmakers are attempting to address potential dependencies that could affect national security and drug availability.
In-depth summary · AI, neutral